Skip to content
Reckitt Benckiser
Search
Join RB’s networks
Facebook
Twitter
RB Early Life Blog
LinkedIn
YouTube
Share
Sitemap
HTML version
Text only version
RB worldwide
Operations around the world
Executive Committee
The Board
RB history
10 years of RB
Contacts
Work & learn at RB
Who we are
Are we right for you?
Your RB career
Our areas of expertise
Graduates
Learn with RB
Career opportunities
Innovators
Products
People
Awards
Our brands
Powerbrands on the shelf
Products around the home
Commercial break
Search RB Brands A-Z
Category performance
Healthcare Brands Employee Reporting
Our responsibility
Environment
Community
Our policies & reports
Investors & media
Reckitt Benckiser offer for SSL-International
Announcements
The talk about RB
Investor information
Category performance
Corporate governance
Share price information
Shareholder information
Contacts
Newsletter Registration
Home
>
Investors & media
>
Category performance
>
Health Care
Investors & media
Reckitt Benckiser offer for SSL-International
Announcements
The talk about RB
Investor information
Category performance
Fabric Care
Surface Care
Dishwashing
Home Care
Health Care
Personal Care
Food
Pharmaceutical
Corporate governance
Share price information
Shareholder information
Contacts
Newsletter Registration
Health Care
Market Position
Nurofen and Gaviscon are leading Analgesic and Gastro-Intestinal brands in Europe and Australia. Strepsils is No.1 in Sore Throat globally. Clearasil is the No:1 brand in Europe across all markets it plays in.
26%
of net revenues
(Health and personal care combined figure)
Health Care
Category profile
Products in this category relieve common health problems. Analgesics, Cold/Flu/Sore Throat and Gastro-Intestinals are generally over the counter medications for common ailments such as pain, fever, cold, flu, sore throat or heartburn.
Market position
Nurofen and Gaviscon are leading Analgesic and Gastro-Intestinal brands in Europe and Australia. Strepsils is No.1 in Sore Throat globally. Mucinex is the No. 1 cough brand in the US.
Click on the key brands in this category to find out more:
Strepsils
|
Mucinex
|
Nurofen
|
Gaviscon
Strepsils
Strepsils is the world's leading sore throat medicine. Trusted by consumers and pharmacists alike, this leading brand is now present in over 100 countries. From its inception as a sore throat gargle in 1950, the range has grown to a wide range of both lozenges and sprays, giving consumers the choice they want for treating their sore throats.
Principal Markets
Europe, Asia, Australasia, Africa and Middle East.
Back to top
Mucinex
Mucinex is the US' leading cough and decongestion remedy. This brand came with the acquisition of the Adams business.
Principal Markets
Mucinex is the US’ leading cough and decongestion remedy.
Back to top
Nurofen
Available in 90 countries, Nurofen is the fastest growing analgesic brand globally and the leading analgesic brand in UK, Australia and New Zealand. Nurofen is available in a variety of formats including tablets, gel caps and liquids. Its range includes Nurofen for Children and heat patches for back pain and menstrual pain.
Principal Markets
Nurofen’s top 5 markets are UK, Australia, France, Russia and Belgium.
Back to top
Gaviscon
Gaviscon is a well-established heartburn and indigestion remedy which provides long lasting relief though its unique raft-forming mode of action. It is prescribed by doctors and recommended by pharmacists and sufferers alike. Gaviscon Advance is stronger and offers longer lasting relief. Following its UK launch in 1997, it is now available in a number of countries globally.
Principal Markets
Africa & Middle East, Asia Pacific, Europe, Latin America, South Asia.
Back to top
Print this page